Are buccal cancers in India and Canada any different?
โ Scribed by K.A. Pathak; R.W. Nason; S.D. Talole; A.A. Abdoh
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 89 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Background and objective
To compare the treatment outcomes of squamous cell carcinoma (SCC) of buccal mucosa in India and Canada.
Methods
We compared the outcome of 169 patients with SCC of buccal mucosa treated at Tata Memorial Hospital (TMH), India with 64 matched patients from Cancer Care Manitoba (CCMB), Canada. Overall and cause specific survivals for the two geographical groups were calculated by KaplanโMeir method and compared using log rank test. Cox regression analysis was used to see impact of independent variables.
Results
At 5 years, CCMB patients had lower over all survival (57.4% vs. 67.1%; Pโ=โ0.002) than TMH ones but similar cause specific survival (76.4% vs. 74.2%; Pโ=โ0.690). Age had an independent influence on both over all and cause specific survival. After adjusting for the age confounding in the Cox proportional hazard model there was no difference in the overall survival of the two groups (HRโ=โ0.84; 95% CIโ=โ0.51, 1.40; Pโ=โ0.509). Radiated patients had three times higher risk of dying of disease than surgically treated ones (HRโ=โ3.03; 95% CIโ=โ1.64, 5.60; Pโ<โ0.001).
Conclusions
There was no difference in the cause specific survival between the two groups. Apparent difference in the overall survival was due to the difference in the age of presentation. J. Surg. Oncol. 2008;97:529โ532. ยฉ 2008 WileyโLiss, Inc.
๐ SIMILAR VOLUMES
## Abstract Angiogenesis is a key in cancer progression and its regulators are released both by the tumor cells and the stroma. Dietary phytoestrogens, such as the lignan enterolactone (ENL) and the isoflavone genistein (GEN), may differently affect breast cancer growth. In this study, human breast
## Abstract __Background__: Patient preferences can affect colorectal cancer (CRC) screening test use. We compared utilityโbased preferences for alternative CRC screening tests from a statedโpreference discreteโchoice survey of the general population and physicians in Canada and the United States.